Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhabdomyosarcoma | 22 | 2023 | 358 | 2.510 |
Why?
|
Bone Neoplasms | 22 | 2023 | 2527 | 0.970 |
Why?
|
Osteosarcoma | 11 | 2022 | 896 | 0.850 |
Why?
|
Urogenital Neoplasms | 2 | 2018 | 131 | 0.640 |
Why?
|
Rhabdomyosarcoma, Alveolar | 7 | 2017 | 42 | 0.640 |
Why?
|
Muscle Neoplasms | 2 | 2015 | 130 | 0.550 |
Why?
|
Cytodiagnosis | 5 | 2019 | 447 | 0.530 |
Why?
|
Teratoma | 2 | 2023 | 404 | 0.520 |
Why?
|
ras Proteins | 2 | 2018 | 1055 | 0.470 |
Why?
|
Biopsy, Fine-Needle | 6 | 2014 | 1118 | 0.430 |
Why?
|
Head and Neck Neoplasms | 4 | 2018 | 2894 | 0.410 |
Why?
|
Soft Tissue Neoplasms | 11 | 2018 | 1158 | 0.400 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 19 | 2023 | 11733 | 0.350 |
Why?
|
Rhabdomyosarcoma, Embryonal | 5 | 2022 | 99 | 0.350 |
Why?
|
Sarcoma | 7 | 2023 | 1800 | 0.340 |
Why?
|
Paired Box Transcription Factors | 5 | 2018 | 206 | 0.320 |
Why?
|
Child | 59 | 2023 | 80152 | 0.280 |
Why?
|
In Situ Hybridization, Fluorescence | 10 | 2021 | 2509 | 0.270 |
Why?
|
Anaplasia | 2 | 2020 | 16 | 0.270 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2021 | 1605 | 0.260 |
Why?
|
Surgical Flaps | 5 | 2008 | 1670 | 0.240 |
Why?
|
Child, Preschool | 41 | 2023 | 42224 | 0.240 |
Why?
|
Infant | 33 | 2023 | 36169 | 0.240 |
Why?
|
Scapula | 2 | 1999 | 173 | 0.240 |
Why?
|
Pathology | 1 | 2007 | 269 | 0.230 |
Why?
|
Gene Fusion | 3 | 2022 | 355 | 0.210 |
Why?
|
Carcinoma, Papillary | 3 | 2018 | 785 | 0.210 |
Why?
|
Lymphangioma | 1 | 2023 | 61 | 0.210 |
Why?
|
Immunohistochemistry | 12 | 2015 | 11067 | 0.200 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2021 | 43 | 0.190 |
Why?
|
Receptors, Cell Surface | 3 | 2015 | 2802 | 0.190 |
Why?
|
Disease-Free Survival | 12 | 2023 | 6819 | 0.190 |
Why?
|
Hedgehog Proteins | 2 | 2018 | 769 | 0.190 |
Why?
|
Mitochondrial Diseases | 2 | 2015 | 342 | 0.180 |
Why?
|
Myogenin | 4 | 2014 | 54 | 0.170 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4947 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2023 | 9278 | 0.160 |
Why?
|
Lymphoma, T-Cell | 1 | 2002 | 303 | 0.160 |
Why?
|
Orbital Neoplasms | 2 | 2012 | 222 | 0.160 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3534 | 0.160 |
Why?
|
Cartilage | 3 | 1999 | 807 | 0.150 |
Why?
|
Kidney Glomerulus | 1 | 2020 | 567 | 0.150 |
Why?
|
Doxorubicin | 7 | 2023 | 2224 | 0.150 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2023 | 492 | 0.150 |
Why?
|
Thyroid Neoplasms | 3 | 2018 | 2330 | 0.150 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 59 | 0.140 |
Why?
|
Adolescent | 34 | 2023 | 88298 | 0.140 |
Why?
|
Translocation, Genetic | 4 | 2021 | 1391 | 0.140 |
Why?
|
DNA Mutational Analysis | 5 | 2018 | 4107 | 0.140 |
Why?
|
Giant Cell Tumors | 2 | 1997 | 89 | 0.140 |
Why?
|
Temporal Bone | 1 | 2002 | 683 | 0.140 |
Why?
|
Spleen | 1 | 2023 | 2290 | 0.140 |
Why?
|
Muscle Cells | 1 | 2018 | 195 | 0.140 |
Why?
|
Neoplasms | 4 | 2019 | 22140 | 0.140 |
Why?
|
Humans | 102 | 2023 | 761208 | 0.140 |
Why?
|
Testicular Neoplasms | 1 | 2023 | 801 | 0.140 |
Why?
|
Meningitis, Aseptic | 1 | 1996 | 59 | 0.130 |
Why?
|
Chorioamnionitis | 2 | 1994 | 156 | 0.130 |
Why?
|
Gaucher Disease | 1 | 2017 | 110 | 0.130 |
Why?
|
Etoposide | 5 | 2023 | 635 | 0.130 |
Why?
|
Vincristine | 6 | 2023 | 1036 | 0.130 |
Why?
|
Autopsy | 3 | 2014 | 1010 | 0.130 |
Why?
|
Combined Modality Therapy | 10 | 2023 | 8519 | 0.130 |
Why?
|
Obstetric Labor, Premature | 2 | 1994 | 272 | 0.130 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 183 | 0.130 |
Why?
|
Cytochrome Reductases | 1 | 2015 | 9 | 0.130 |
Why?
|
Growth Plate | 2 | 1999 | 275 | 0.130 |
Why?
|
Amniotic Fluid | 2 | 1994 | 378 | 0.120 |
Why?
|
Cisplatin | 6 | 2019 | 1652 | 0.120 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2015 | 38 | 0.120 |
Why?
|
Microvilli | 1 | 2015 | 234 | 0.120 |
Why?
|
22q11 Deletion Syndrome | 1 | 2014 | 18 | 0.120 |
Why?
|
Male | 60 | 2023 | 360693 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2019 | 803 | 0.120 |
Why?
|
Survival Rate | 7 | 2020 | 12728 | 0.120 |
Why?
|
Forensic Medicine | 1 | 2014 | 64 | 0.120 |
Why?
|
Mucolipidoses | 1 | 2015 | 82 | 0.120 |
Why?
|
Bone Transplantation | 1 | 1999 | 923 | 0.120 |
Why?
|
Pathology, Clinical | 1 | 2018 | 376 | 0.110 |
Why?
|
Malabsorption Syndromes | 1 | 2015 | 135 | 0.110 |
Why?
|
Female | 65 | 2023 | 392544 | 0.110 |
Why?
|
Skin Transplantation | 1 | 1999 | 1091 | 0.110 |
Why?
|
Peptide Termination Factors | 1 | 2014 | 56 | 0.110 |
Why?
|
Acidosis, Lactic | 1 | 2015 | 146 | 0.110 |
Why?
|
Uterine Diseases | 1 | 1994 | 108 | 0.110 |
Why?
|
Gadolinium DTPA | 1 | 2017 | 823 | 0.110 |
Why?
|
Optic Atrophy | 1 | 2014 | 79 | 0.110 |
Why?
|
Rhabdomyoma | 1 | 2013 | 56 | 0.110 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 346 | 0.110 |
Why?
|
Chondroma | 1 | 2013 | 53 | 0.110 |
Why?
|
Diagnosis, Differential | 9 | 2018 | 12976 | 0.110 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 194 | 0.110 |
Why?
|
Muscles | 1 | 2018 | 1568 | 0.110 |
Why?
|
Sarcoma, Clear Cell | 1 | 2013 | 72 | 0.110 |
Why?
|
Leigh Disease | 1 | 2014 | 89 | 0.110 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2016 | 323 | 0.100 |
Why?
|
Contracture | 2 | 1994 | 235 | 0.100 |
Why?
|
Dactinomycin | 5 | 2018 | 304 | 0.100 |
Why?
|
Methotrexate | 5 | 2019 | 1718 | 0.100 |
Why?
|
Cardiotonic Agents | 1 | 2015 | 540 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1528 | 0.100 |
Why?
|
Gene Amplification | 1 | 1996 | 1084 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2024 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6486 | 0.100 |
Why?
|
Metabolism, Inborn Errors | 1 | 2014 | 284 | 0.100 |
Why?
|
Heart Aneurysm | 1 | 2012 | 114 | 0.100 |
Why?
|
Prognosis | 12 | 2020 | 29687 | 0.100 |
Why?
|
Limb Deformities, Congenital | 1 | 1992 | 136 | 0.100 |
Why?
|
Frameshift Mutation | 1 | 2013 | 392 | 0.100 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4909 | 0.090 |
Why?
|
Genes, p53 | 1 | 2013 | 713 | 0.090 |
Why?
|
Thyroid Nodule | 2 | 2016 | 763 | 0.090 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2014 | 283 | 0.090 |
Why?
|
Drug Resistance, Multiple | 2 | 2007 | 255 | 0.090 |
Why?
|
Cyclophosphamide | 5 | 2023 | 2219 | 0.090 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39126 | 0.090 |
Why?
|
Antibodies, Monoclonal | 6 | 2023 | 9187 | 0.090 |
Why?
|
Femur | 2 | 2013 | 1308 | 0.090 |
Why?
|
Hypercalcemia | 1 | 2013 | 423 | 0.090 |
Why?
|
Young Adult | 13 | 2023 | 59221 | 0.090 |
Why?
|
Paraganglioma | 1 | 2012 | 143 | 0.090 |
Why?
|
Osteotomy | 1 | 2015 | 836 | 0.080 |
Why?
|
Siblings | 1 | 2014 | 824 | 0.080 |
Why?
|
Adult | 32 | 2023 | 221119 | 0.080 |
Why?
|
Thyroid Gland | 1 | 2016 | 1169 | 0.080 |
Why?
|
Ornithine | 1 | 2009 | 79 | 0.080 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1130 | 0.080 |
Why?
|
Foot Ulcer | 1 | 2009 | 62 | 0.080 |
Why?
|
Cataract | 1 | 2015 | 828 | 0.080 |
Why?
|
World Health Organization | 1 | 2015 | 1321 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2058 | 0.080 |
Why?
|
Infant, Newborn | 10 | 2023 | 26199 | 0.080 |
Why?
|
Topotecan | 3 | 2009 | 131 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 1996 | 1963 | 0.080 |
Why?
|
Heart Neoplasms | 1 | 2012 | 364 | 0.080 |
Why?
|
Treatment Outcome | 15 | 2018 | 64681 | 0.080 |
Why?
|
Skin | 2 | 2009 | 4473 | 0.070 |
Why?
|
RNA-Binding Protein EWS | 3 | 2021 | 210 | 0.070 |
Why?
|
PAX7 Transcription Factor | 3 | 2014 | 55 | 0.070 |
Why?
|
Pressure Ulcer | 1 | 2009 | 157 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2014 | 4567 | 0.070 |
Why?
|
Abnormalities, Multiple | 2 | 2012 | 1423 | 0.070 |
Why?
|
Sarcoidosis | 1 | 2013 | 537 | 0.070 |
Why?
|
Mutation | 4 | 2018 | 30002 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2016 | 2881 | 0.070 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2007 | 55 | 0.070 |
Why?
|
Sclerosis | 2 | 2005 | 210 | 0.070 |
Why?
|
Ear Neoplasms | 1 | 2008 | 118 | 0.070 |
Why?
|
Ear, External | 1 | 2008 | 165 | 0.070 |
Why?
|
Heel | 2 | 2009 | 38 | 0.070 |
Why?
|
Ifosfamide | 3 | 2015 | 232 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6067 | 0.070 |
Why?
|
Extremities | 1 | 1992 | 867 | 0.070 |
Why?
|
Neoadjuvant Therapy | 2 | 2015 | 2827 | 0.070 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1129 | 0.070 |
Why?
|
Ectromelia | 2 | 1999 | 28 | 0.070 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2007 | 233 | 0.070 |
Why?
|
Contrast Media | 2 | 2017 | 5311 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2254 | 0.070 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 1061 | 0.070 |
Why?
|
North America | 2 | 2023 | 1284 | 0.070 |
Why?
|
Image Enhancement | 1 | 2017 | 2888 | 0.070 |
Why?
|
Antigens, CD | 1 | 1996 | 4009 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2013 | 1852 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 2 | 1994 | 2150 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6567 | 0.060 |
Why?
|
Hand Deformities, Congenital | 2 | 1999 | 174 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 501 | 0.060 |
Why?
|
Hepatolenticular Degeneration | 1 | 2005 | 72 | 0.060 |
Why?
|
Kidney Diseases | 2 | 2014 | 2092 | 0.060 |
Why?
|
Knee Joint | 1 | 2013 | 1678 | 0.060 |
Why?
|
Survival Analysis | 7 | 2020 | 10088 | 0.060 |
Why?
|
Australia | 2 | 2019 | 1246 | 0.060 |
Why?
|
Chondrosarcoma | 2 | 1997 | 295 | 0.060 |
Why?
|
Interleukin-1 | 2 | 1998 | 1250 | 0.050 |
Why?
|
Heart Arrest | 1 | 1993 | 1513 | 0.050 |
Why?
|
Mitral Valve | 1 | 2012 | 1465 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2208 | 0.050 |
Why?
|
Liver Failure, Acute | 1 | 2005 | 181 | 0.050 |
Why?
|
Sacrum | 1 | 2005 | 275 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2009 | 938 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 17897 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 2133 | 0.050 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2002 | 36 | 0.050 |
Why?
|
Liver | 2 | 2017 | 7514 | 0.050 |
Why?
|
Hepatitis, Autoimmune | 1 | 2005 | 172 | 0.050 |
Why?
|
In Situ Hybridization | 5 | 1998 | 1900 | 0.050 |
Why?
|
Retrospective Studies | 18 | 2023 | 80674 | 0.050 |
Why?
|
Burns | 1 | 1994 | 1875 | 0.050 |
Why?
|
Glucose | 1 | 1994 | 4342 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 7 | 2017 | 36415 | 0.050 |
Why?
|
Staining and Labeling | 4 | 2018 | 1080 | 0.050 |
Why?
|
Interleukin-6 | 3 | 1998 | 3210 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4021 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2013 | 3111 | 0.050 |
Why?
|
Paraffin Embedding | 3 | 2013 | 302 | 0.050 |
Why?
|
Peptide Hormones | 1 | 2002 | 132 | 0.050 |
Why?
|
MyoD Protein | 3 | 2007 | 141 | 0.050 |
Why?
|
Barrett Esophagus | 2 | 1998 | 492 | 0.050 |
Why?
|
Bile Duct Neoplasms | 1 | 2007 | 607 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 1993 | 2021 | 0.050 |
Why?
|
Sensitivity and Specificity | 7 | 2014 | 14675 | 0.050 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2553 | 0.050 |
Why?
|
Interferon-alpha | 2 | 2015 | 907 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2018 | 11509 | 0.040 |
Why?
|
Myocardium | 1 | 2013 | 4746 | 0.040 |
Why?
|
DNA | 1 | 2014 | 7189 | 0.040 |
Why?
|
Risk Factors | 5 | 2022 | 74239 | 0.040 |
Why?
|
Liver Neoplasms | 3 | 2011 | 4309 | 0.040 |
Why?
|
Aortic Valve Stenosis | 1 | 2012 | 2018 | 0.040 |
Why?
|
Polyethylene Glycols | 2 | 2015 | 1187 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8003 | 0.040 |
Why?
|
Schwann Cells | 1 | 2000 | 196 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2007 | 1855 | 0.040 |
Why?
|
Ankle | 1 | 1982 | 350 | 0.040 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2005 | 782 | 0.040 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2000 | 134 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 890 | 0.040 |
Why?
|
Femur Head Necrosis | 1 | 1999 | 132 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.040 |
Why?
|
Epiphyses | 1 | 1999 | 191 | 0.040 |
Why?
|
Middle Aged | 19 | 2020 | 220853 | 0.040 |
Why?
|
Trigeminal Nerve | 1 | 2000 | 248 | 0.040 |
Why?
|
Wound Healing | 1 | 2009 | 2800 | 0.040 |
Why?
|
Histological Techniques | 1 | 1998 | 193 | 0.040 |
Why?
|
Synovitis, Pigmented Villonodular | 1 | 1998 | 32 | 0.040 |
Why?
|
Pain | 1 | 2013 | 5072 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4673 | 0.040 |
Why?
|
Osteoclasts | 2 | 2002 | 711 | 0.040 |
Why?
|
Genes, MDR | 1 | 1997 | 36 | 0.040 |
Why?
|
Gene Expression | 4 | 2013 | 7571 | 0.040 |
Why?
|
Osteochondroma | 1 | 1997 | 44 | 0.040 |
Why?
|
Ankle Injuries | 1 | 2001 | 338 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4513 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4251 | 0.030 |
Why?
|
Meningitis, Viral | 1 | 1996 | 50 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2017 | 350 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7400 | 0.030 |
Why?
|
Cytogenetic Analysis | 2 | 2007 | 270 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2017 | 361 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2013 | 1743 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 1998 | 4340 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 1998 | 389 | 0.030 |
Why?
|
Morocco | 1 | 2015 | 30 | 0.030 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2015 | 32 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2009 | 6341 | 0.030 |
Why?
|
Cartilage Diseases | 1 | 1997 | 157 | 0.030 |
Why?
|
DNA Probes | 1 | 1996 | 542 | 0.030 |
Why?
|
Metaplasia | 1 | 1996 | 324 | 0.030 |
Why?
|
Sarcoma, Synovial | 1 | 1996 | 153 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1996 | 282 | 0.030 |
Why?
|
Giant Cell Tumor of Bone | 1 | 1996 | 118 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9428 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2000 | 2561 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23416 | 0.030 |
Why?
|
Aged | 15 | 2016 | 169288 | 0.030 |
Why?
|
Ventricular Dysfunction | 1 | 2015 | 144 | 0.030 |
Why?
|
Radiotherapy | 2 | 2012 | 1499 | 0.030 |
Why?
|
Methylmalonyl-CoA Mutase | 1 | 2014 | 23 | 0.030 |
Why?
|
Ploidies | 1 | 1994 | 285 | 0.030 |
Why?
|
Iopamidol | 1 | 2014 | 186 | 0.030 |
Why?
|
Neoplasm Staging | 5 | 2010 | 11119 | 0.030 |
Why?
|
Aged, 80 and over | 8 | 2016 | 58952 | 0.030 |
Why?
|
Carcinoma, Small Cell | 1 | 1996 | 420 | 0.030 |
Why?
|
Diet, Protein-Restricted | 1 | 2014 | 72 | 0.030 |
Why?
|
Biopsy | 3 | 2002 | 6781 | 0.030 |
Why?
|
HMGA2 Protein | 1 | 2014 | 101 | 0.030 |
Why?
|
Mediastinal Neoplasms | 1 | 1996 | 401 | 0.030 |
Why?
|
Ossification, Heterotopic | 1 | 1996 | 235 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 1996 | 315 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 174 | 0.030 |
Why?
|
Asia | 1 | 2015 | 622 | 0.030 |
Why?
|
Cohort Studies | 4 | 2019 | 41496 | 0.030 |
Why?
|
Nephritis | 1 | 2014 | 147 | 0.030 |
Why?
|
Nephrocalcinosis | 1 | 2013 | 52 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1613 | 0.030 |
Why?
|
Consanguinity | 1 | 2015 | 457 | 0.030 |
Why?
|
Bone Resorption | 1 | 1997 | 723 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2005 | 2332 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2005 | 2223 | 0.030 |
Why?
|
Simplexvirus | 1 | 1996 | 801 | 0.030 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2012 | 29 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3777 | 0.030 |
Why?
|
Amniotic Band Syndrome | 1 | 1992 | 22 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2015 | 348 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 1996 | 677 | 0.030 |
Why?
|
Ohio | 1 | 2013 | 322 | 0.030 |
Why?
|
Fatal Outcome | 2 | 1996 | 1838 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20588 | 0.030 |
Why?
|
Foot Deformities, Congenital | 1 | 1992 | 59 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2009 | 15308 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 550 | 0.030 |
Why?
|
Esophagus | 1 | 1998 | 1036 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2014 | 295 | 0.020 |
Why?
|
History, Ancient | 1 | 2012 | 213 | 0.020 |
Why?
|
Kidney Tubules, Proximal | 1 | 2014 | 382 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5300 | 0.020 |
Why?
|
Shoulder | 1 | 1994 | 301 | 0.020 |
Why?
|
Hydronephrosis | 1 | 2013 | 271 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1155 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 320 | 0.020 |
Why?
|
Mitochondria | 2 | 2015 | 3620 | 0.020 |
Why?
|
Axilla | 1 | 1994 | 624 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2015 | 3512 | 0.020 |
Why?
|
Vitamin B 12 | 1 | 2014 | 524 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12474 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2683 | 0.020 |
Why?
|
Developing Countries | 1 | 2023 | 2863 | 0.020 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2012 | 190 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2016 | 908 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3551 | 0.020 |
Why?
|
Fibula | 1 | 1992 | 266 | 0.020 |
Why?
|
Fetal Death | 1 | 2012 | 435 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5366 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2009 | 13385 | 0.020 |
Why?
|
Hepatocytes | 1 | 2017 | 1231 | 0.020 |
Why?
|
Histocytological Preparation Techniques | 1 | 2009 | 33 | 0.020 |
Why?
|
DNA, Viral | 1 | 1996 | 2195 | 0.020 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2013 | 433 | 0.020 |
Why?
|
Radius | 1 | 1992 | 442 | 0.020 |
Why?
|
Mosaicism | 1 | 1993 | 477 | 0.020 |
Why?
|
Research Report | 1 | 2012 | 367 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1265 | 0.020 |
Why?
|
Karyotyping | 2 | 2006 | 1172 | 0.020 |
Why?
|
Atrophy | 1 | 2014 | 1633 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 1992 | 982 | 0.020 |
Why?
|
Bone Remodeling | 1 | 1992 | 583 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2010 | 492 | 0.020 |
Why?
|
Ultrasonography | 2 | 2013 | 5969 | 0.020 |
Why?
|
Pediatrics | 1 | 2004 | 3590 | 0.020 |
Why?
|
Prospective Studies | 5 | 2016 | 54435 | 0.020 |
Why?
|
Incidental Findings | 1 | 2013 | 698 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2012 | 858 | 0.020 |
Why?
|
Kidney | 2 | 2014 | 7033 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3590 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3423 | 0.020 |
Why?
|
Nephrectomy | 1 | 2013 | 938 | 0.020 |
Why?
|
Base Sequence | 2 | 1996 | 12404 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2014 | 974 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 5993 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10422 | 0.020 |
Why?
|
Brain | 1 | 2014 | 27092 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 1994 | 1590 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5828 | 0.020 |
Why?
|
Thyrotropin | 1 | 2010 | 833 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1302 | 0.020 |
Why?
|
Tibia | 1 | 1992 | 1070 | 0.020 |
Why?
|
Treatment Failure | 2 | 2004 | 2643 | 0.020 |
Why?
|
Phenotype | 2 | 2015 | 16575 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1996 | 17598 | 0.020 |
Why?
|
Chromosome Banding | 1 | 2006 | 260 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1993 | 1767 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 1989 | 0.020 |
Why?
|
Radiography | 2 | 2013 | 6974 | 0.020 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2006 | 192 | 0.020 |
Why?
|
Gene Deletion | 1 | 2013 | 2658 | 0.020 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2006 | 104 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 14025 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3634 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6504 | 0.020 |
Why?
|
Cystoscopy | 1 | 2005 | 131 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14392 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8642 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1992 | 982 | 0.010 |
Why?
|
Pregnancy | 4 | 2012 | 29893 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2011 | 20982 | 0.010 |
Why?
|
Family | 1 | 2015 | 3192 | 0.010 |
Why?
|
Urine | 1 | 2005 | 362 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2013 | 2159 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2854 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9327 | 0.010 |
Why?
|
Bacteria | 1 | 1994 | 2190 | 0.010 |
Why?
|
Swine | 1 | 2013 | 5909 | 0.010 |
Why?
|
Biological Assay | 1 | 2006 | 623 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18384 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2008 | 5871 | 0.010 |
Why?
|
Back | 1 | 1982 | 64 | 0.010 |
Why?
|
Mucins | 1 | 2005 | 569 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4921 | 0.010 |
Why?
|
Leg Length Inequality | 1 | 1982 | 56 | 0.010 |
Why?
|
Macrophages | 1 | 1996 | 5753 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1746 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 1992 | 1658 | 0.010 |
Why?
|
Biopsy, Needle | 2 | 1996 | 1624 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4052 | 0.010 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2002 | 327 | 0.010 |
Why?
|
Life Tables | 1 | 2001 | 364 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20119 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 8998 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9520 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81326 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 24021 | 0.010 |
Why?
|
Calcium | 1 | 2013 | 5719 | 0.010 |
Why?
|
Animals | 3 | 2020 | 168079 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2001 | 9025 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 39957 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 326 | 0.010 |
Why?
|
Bronchiolitis Obliterans | 1 | 2001 | 213 | 0.010 |
Why?
|
Melphalan | 1 | 2001 | 420 | 0.010 |
Why?
|
Echocardiography | 1 | 2012 | 5006 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2006 | 2897 | 0.010 |
Why?
|
S100 Proteins | 1 | 2000 | 216 | 0.010 |
Why?
|
Bone Marrow Diseases | 1 | 2001 | 233 | 0.010 |
Why?
|
Vimentin | 1 | 2000 | 255 | 0.010 |
Why?
|
Research Design | 1 | 2014 | 6180 | 0.010 |
Why?
|
Neurofibromin 2 | 1 | 2000 | 269 | 0.010 |
Why?
|
Medical Records | 1 | 2004 | 1409 | 0.010 |
Why?
|
United States | 3 | 2018 | 72339 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2635 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13511 | 0.010 |
Why?
|
Foot | 1 | 1982 | 575 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2005 | 1780 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 13632 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5250 | 0.010 |
Why?
|
Ankle Joint | 1 | 2001 | 446 | 0.010 |
Why?
|
Osteoblasts | 1 | 2002 | 1144 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1997 | 416 | 0.010 |
Why?
|
Cecal Neoplasms | 1 | 1996 | 27 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 1994 | 26071 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2002 | 1803 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2001 | 1784 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8530 | 0.010 |
Why?
|
Remission Induction | 1 | 2001 | 2392 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12341 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3594 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18220 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1703 | 0.010 |
Why?
|
Bone Diseases | 1 | 1997 | 418 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1995 | 1545 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 13367 | 0.010 |
Why?
|
Anus Neoplasms | 1 | 1996 | 330 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2001 | 6223 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 1995 | 457 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1993 | 410 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15721 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 1993 | 430 | 0.010 |
Why?
|
Incidence | 2 | 2004 | 21365 | 0.010 |
Why?
|
Databases, Factual | 1 | 2006 | 7966 | 0.010 |
Why?
|
Esophagoscopy | 1 | 1992 | 398 | 0.010 |
Why?
|
X Chromosome | 1 | 1993 | 816 | 0.010 |
Why?
|
Data Collection | 1 | 1998 | 3320 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3418 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1993 | 1386 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12052 | 0.000 |
Why?
|
Population Surveillance | 1 | 1998 | 2598 | 0.000 |
Why?
|
Fetal Diseases | 1 | 1993 | 912 | 0.000 |
Why?
|
Sepsis | 1 | 2001 | 2585 | 0.000 |
Why?
|
Bone and Bones | 1 | 1997 | 2568 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 3803 | 0.000 |
Why?
|
Health Care Costs | 1 | 1998 | 3239 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2002 | 15841 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1996 | 2527 | 0.000 |
Why?
|
Placenta | 1 | 1993 | 1711 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2000 | 7851 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 12747 | 0.000 |
Why?
|
Cell Line | 1 | 1993 | 15545 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1993 | 18926 | 0.000 |
Why?
|